Prospective Memory in Parkinson's Disease (ProMem)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
40 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Community Movement Disorder Clinic at Washington University St. Louis
Clinically definite PD
40-70 years old
Hoehn and Yahr stage I,II,III
Currently treated with Levodopa/carbidopa
40-70 years old
Spouses of PD Group preferred
PD Group and Control Group:
Significant neurological problems
Significant current psychiatric diagnoses
Mini Mental Status Exam score < 24 (MMSE)
Any significant abnormality on brain imaging
Control Participants met the same exclusion criteria described above as well as a biological family history of PD